These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25474187)

  • 1. Outcomes associated with switching from monotherapy to adjunctive therapy for patients with partial onset seizures.
    Wang Z; Li X; Powers A; Cavazos JE
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):349-55. PubMed ID: 25474187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost comparison of alternative regimens for treatment-refractory partial seizure disorder: an econometric analysis.
    Lee WC; Hoffmann MS; Arcona S; D'Souza J; Wang Q; Pashos CL
    Clin Ther; 2005 Oct; 27(10):1629-38. PubMed ID: 16330300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States.
    Chen SY; Wu N; Boulanger L; Sacco P
    J Med Econ; 2013; 16(2):240-8. PubMed ID: 23171361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and economic burden of breakthrough seizures.
    Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
    Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare resource utilization and costs before and after lacosamide initiation as adjunctive therapy among patients with epilepsy in the United States.
    Fishman J; Martin M; Labiner DM; Lew CR; Johnson BH
    Epilepsy Behav; 2019 Oct; 99():106331. PubMed ID: 31399339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
    Uthman BM; Almas M; Emir B; Giordano S; Leon T
    Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy.
    Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
    Eur J Paediatr Neurol; 2012 Sep; 16(5):449-58. PubMed ID: 22261080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeks.
    Piña-Garza JE; Schiemann-Delgado J; Yang H; Duncan B; Hadac J; Hunter SJ
    Clin Ther; 2010 Oct; 32(11):1935-50. PubMed ID: 21095488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy--preliminary results].
    Picot MC; Neveu D; Kahane P; Crespel A; Gélisse P; Hirsch E; Derambure P; Dupont S; Landré E; Chassoux F; Valton L; Vignal JP; Marchal C; Rougier A; Lamy C; Semah F; Biraben A; Arzimanoglou A; Petit J; Thomas P; Dujols P; Ryvlin P
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S354-67. PubMed ID: 15331984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
    Pasha I; Kamate M; Didagi SK
    Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States.
    Ivanova JI; Birnbaum HG; Kidolezi Y; Qiu Y; Mallett D; Caleo S
    Epilepsia; 2010 May; 51(5):838-44. PubMed ID: 20002150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacosamide as adjunctive therapy for partial-onset epileptic seizures: a review of the clinical and economic literature.
    Simoens S
    Curr Med Res Opin; 2011 Jul; 27(7):1329-38. PubMed ID: 21561394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine extended-release as adjunctive therapy for partial seizures.
    Naritoku DK; Warnock CR; Messenheimer JA; Borgohain R; Evers S; Guekht AB; Karlov VA; Lee BI; Pohl LR
    Neurology; 2007 Oct; 69(16):1610-8. PubMed ID: 17938371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.
    Brodie MJ; Lerche H; Gil-Nagel A; Elger C; Hall S; Shin P; Nohria V; Mansbach H;
    Neurology; 2010 Nov; 75(20):1817-24. PubMed ID: 20944074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of comorbidities on medical care use and cost among refractory patients with partial seizure disorder.
    Lee WC; Arcona S; Thomas SK; Wang Q; Hoffmann MS; Pashos CL
    Epilepsy Behav; 2005 Aug; 7(1):123-6. PubMed ID: 15939673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
    Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
    Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early clinical experience with lacosamide as adjunctive therapy in patients with refractory focal epilepsy and nocturnal seizures.
    García-Morales I; Delgado RT; Falip M; Campos D; García ME; Gil-Nagel A
    Seizure; 2011 Dec; 20(10):801-4. PubMed ID: 21917484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam.
    Strzelczyk A; Schubert-Bast S; Reese JP; Rosenow F; Stephani U; Boor R
    Epilepsy Behav; 2014 May; 34():86-91. PubMed ID: 24727467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.